France cancels order for Merck's Covid-19 antiviral drug
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 16, 2022
MONDAY, MAY 16, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
France cancels order for Merck's Covid-19 antiviral drug

Coronavirus chronicle

Reuters
23 December, 2021, 10:10 am
Last modified: 23 December, 2021, 10:14 am

Related News

  • Macron suggests new European entity
  • France's Macron sworn in for second term as president
  • Armed robbers strike Chanel jewellery store in Paris and flee on motorbikes
  • France and India call for immediate end to Ukraine hostilities
  • No respite for re-elected Macron as parliamentary elections loom

France cancels order for Merck's Covid-19 antiviral drug

France had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics

Reuters
23 December, 2021, 10:10 am
Last modified: 23 December, 2021, 10:14 am
Photo :Collected
Photo :Collected

France has cancelled its order for Merck & Co's Covid-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.

France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.

"The latest studies weren't good," Olivier Veran told BFM TV.

A spokesperson for Merck said the country's planned purchase did not take place after the French health authority refused to authorise the pill earlier this month.

The company said it continued to work with the European Medicines Association (EMA) on its regulatory review of the drug. It has deals to supply or sell the pill to over 30 countries and has shipped product to 12.

While vaccines are the main weapons against Covid-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.

France had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.

The cancellation would not incur a cost, Veran said.

APPROVAL DECISION

In Italy, the office of the special commissioner for the Covid emergency said on Nov. 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's one.

"The contract has not yet been finalised, but is in progress," a spokesperson for the commissioner told Reuters on Tuesday.

Italian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.

However, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.

"There must and will be an evaluation, independently of the assessments of regulatory bodies," Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.

Germany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.

"This is a binding order," he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.

The EMA is expected to decide whether to approve the Merck and Pfizer pills in the new year.

Pfizer's Paxlovid has shown near 90% efficacy in preventing Covid-19 hospitalisations and deaths in high-risk patients.

France had purchased that drug instead, Veran said, without saying how many doses it had secured.

"France is lined up to get it before the end of January," Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.

Top News / World+Biz

France / Merck Covid-19 Pill

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Citizen's platform for monthly Tk1,000 allowance for unemployed youths 
    Citizen's platform for monthly Tk1,000 allowance for unemployed youths 
  • Photo: PID
    Make best use of funds in effective implementation of SDGs: PM Hasina
  • BPC will sell cheap bulk LPG to private companies due to low bottling capacity
    BPC will sell cheap bulk LPG to private companies due to low bottling capacity

MOST VIEWED

  • A medical worker in a protective suit collects a swab from a resident at a makeshift nucleic acid testing site inside a residential compound under lockdown, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China April 14, 2022. REUTERS/Xihao Jiang
    Shanghai aims for return to normal life from 1 June
  • South Korea's new President Yoon Suk-yeol signs a document as he works at the new Presidential office in Seoul, South Korea, May 10, 2022. Yonhap via REUTERS/File Photo
    S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • North Korean leader Kim Jong Un wears a face mask amid the coronavirus disease (Covid-19) outbreak, while inspecting a pharmacy in Pyongyang, in this undated photo released by North Korea's Korean Central News Agency (KCNA) on May 15, 2022. KCNA via REUTERS
    Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak
  • North Korea reports 15 more suspected Covid-19 deaths
    North Korea reports 15 more suspected Covid-19 deaths
  • Residents line up for nucleic acid tests during lockdown, amid the coronavirus disease (Covid-19) pandemic, in Shanghai, China, May 9, 2022. REUTERS/Aly Song
    Locked-down Shanghai to start gradually reopening malls, other businesses
  • New Zealand Prime Minister Jacinda Ardern. Photo: Collected
    New Zealand Prime Minister Jacinda Ardern tests positive for Covid

Related News

  • Macron suggests new European entity
  • France's Macron sworn in for second term as president
  • Armed robbers strike Chanel jewellery store in Paris and flee on motorbikes
  • France and India call for immediate end to Ukraine hostilities
  • No respite for re-elected Macron as parliamentary elections loom

Features

Bitcoin, by far the largest cryptocurrency, is a terrible substitute for government-issued money. Photo: Reuters

Crypto’s wild week offers a much-needed warning

1h | Panorama
Karst Stone Paper Journal: Write on indestructible stone paper

Karst Stone Paper Journal: Write on indestructible stone paper

2h | Brands
Pesky bugs do not stand a chance against this automatic indoor insect trap

Pesky bugs do not stand a chance against this automatic indoor insect trap

2h | Brands
Wazeenah: Turning furniture into a canvas

Wazeenah: Turning furniture into a canvas

3h | Brands

More Videos from TBS

How can you become proficient as a new team leader?

5h | Videos
Future of newborn baby genome sequencing: Good or Bad?

Future of newborn baby genome sequencing: Good or Bad?

5h | Videos
What Europe-based Fair Wear says about fair price of Bangladeshi cloth

What Europe-based Fair Wear says about fair price of Bangladeshi cloth

18h | Videos
Microplastics found in 5 local sugar brands

Microplastics found in 5 local sugar brands

18h | Videos

Most Read

1
The hostile welcome to Bangladesh
Bangladesh

The hostile welcome to Bangladesh

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
Union Capital asked to return Tk100cr FDR to BATBC 
Banking

Union Capital asked to return Tk100cr FDR to BATBC 

5
Bangladesh gas fields burnt $3m worth of gas in the air in 2021
Energy

Bangladesh gas fields burnt $3m worth of gas in the air in 2021

6
Impact of falling taka against US dollar
Banking

Taka losing more value as global currency market volatility persists

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab